Equipment for obesity studies

Why it matters

Why do obesity trials now need cardiovascular safety monitoring as standard?
The rise of GLP-1 and related weight-loss therapies has raised the evidentiary bar for obesity trials, with regulators and sponsors increasingly expecting cardiovascular outcome data alongside weight change. That means ECGs, blood pressure monitors, and vital signs equipment now sit alongside the metabolic monitoring devices that used to define obesity trial equipment lists on their own.

Body composition, not just body weight, is becoming the outcome that matters
Weight loss alone doesn't distinguish fat loss from muscle loss, and that distinction has become clinically important as newer therapies show different effects on lean mass. Trials are increasingly pairing standard scales with metabolic and body composition monitoring to capture that difference.

Obesity trials were early adopters of decentralised, connected devices
Wearables and connected devices for continued patient monitoring have been part of obesity trial design for longer than in many other therapeutic areas, since tracking activity, sleep, and metabolic markers over time gives a fuller picture than periodic clinic visits alone.

What we do

Our global distribution network puts calibrated equipment on site for obesity studies anywhere in the world, whenever it's needed. Cardiometabolic safety monitoring covers ECGs, blood pressure monitors, and CGM devices. Body composition and activity monitoring covers connected devices and scales. Day-to-day site operations covers refrigerators, freezers, thermometers, and temperature dataloggers. Everything is available fully calibrated and ready to use. If you require equipment supply for an obesity study, get in touch.